Trial Profile
Clinical Trials Insight: 700035611
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2008
Price :
$35
*
At a glance
- Drugs CGEN 50001 (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors Compugen
- 23 Jul 2008 New trial record.